Given the low incidence of cytotoxic CTCL, there have naturally been very few documented instances of phenotypic shift in CTCL between CD4+ and CD8+ phenotypes [2,7-12]. The gene discussed is CD4; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.